Last checked at 
29 Nov 2016 17:29
International Biotechnology Trust plc: New research from Investment Trust Intelligence
International Biotechnology Trust aims to deliver geared capital growth over the long term and - as of this year - income, from a diversified portfolio of small, medium and large biotech and life sciences companies, the vast majority of them based in the United States, with a smaller weighting in Europe.
In this research note, produced by the investment companies team at Kepler Partners, we examine the portfolio in detail and talk to fund managers Carl Harald Janson, Ailsa Craig and Kate Bingham about their approach to stock selection, and the outlook for biotech in a 'post-Clinton' world.
Click here to read the full report
Visit http://www.trustintelligence.co.uk for more high quality independent investment trust research...
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
About this service
Investment Trust Intelligence for private investors is not just another news and research website. Our aim is to create a library of high quality investment strategy research, fund analysis and useful guides for private investors, all written in-house by experienced analysts on the investment companies team at Kepler Partners.
We are focused entirely on investment trusts, however we believe that it helps to understand them better if they are placed on a level playing field with OEICs, so you will see comparisons between the two in these pages often.
Our content falls into three categories;
· Investment strategy articles are designed to highlight opportunities and developments which are of interest to investment trust investors, positive or negative.
· Fund research focuses on individual trusts, examining them in detail to create a snapshot picture which you can use to decide whether or not you want to invest in them.
· Educational output is split into simple guides, designed to help beginners understand how investment trusts work, and more complex guides to sectors, regions and strategies which may be of interest to investors.
We do not produce massive amounts of research. Our focus is on quality, not quantity, so we are unlikely to publish more than four or five articles in a given week. For this reason we recommend that you join our mailing list, and we'll send you an email once a week alerting you to what's new on the site. We won't sell your details, and we won't spam you with useless updates.
How are we funded?
The vast majority of our research is produced on an independent basis, however some of the research we produce is paid for by asset management companies and investment trust boards, who want to raise the profile of the trusts they are responsible for. If a trust has paid us to produce research you will see that this is clearly marked at the top of the page - where you will see the company's logo on the top right. It will also say 'non-independent research' underneath the name of the trust and you can click on this to learn more about our relationship with that client.
We provide information, not advice
While we hope that you find the research we publish useful, and we believe it will help you to make a more informed decision, but we must of course stress that none of the research published here constitutes a recommendation, or advice, and you should not think that - just because we've published a report on a trust - we believe that trust is a 'buy'. Please read our terms and conditions.
If you want to manage your own investments we hope that this website is a useful source of information which helps you to do that, however if you are in any doubt, you should speak to a financial adviser.
Pascal Dowling
Kepler Partners
pascal@keplerpartners.com
www.trustintelligence.co.uk
www.keplerpartners.com
29 November 2016